Lipophilic statins inhibit YAP co-activator transcriptional activity in HCC cells through Rho-mediated modulation of the actin cytoskeleton

By sjmartinez • June 28, 2023

Benhammou JN, Qiao B, Ko A, Sinnett-Smith J, Pisegna J, Rozengurt E. Lipophilic statins inhibit YAP co-activator transcriptional activity in HCC cells through Rho-mediated modulation of the actin cytoskeleton. Am J Physiol Gastrointest Liver Physiol. 2023 Jun 27. doi: 10.1152/ajpgi.00089.2023. Epub ahead of print. PMID: 37366601.

Tags: chemoprevention, Digestive Diseases, Hepatocellular carcinoma, Publications, Statins, Veterans Administration, YAP

High concentrations of L-lysine cause mitochondrial damage and necrosis in isolated pancreatic acinar cells

Végh ET, Balla Z, Dágó Á, Salamah O, Tóth B, Elperin J, Speakman S, Shalbueva N, Pallagi P, Rázga Z, Kiss L, Gukovskaya A, Rakonczay[...]

Social bonds and health: exploring the impact of social relations on oxytocin and brain-gut communication in shaping obesity

Zhang X, Dong TS, Gee GC, Kilpatrick LA, Beltran-Sanchez H, Wang MC, Vaughan A, Church A. Social bonds and health: exploring the impact of social[...]

Unraveling the Complexity: A Case of Systemic Lupus Erythematosus, Warm Autoimmune Hemolytic Anemia, and Autoimmune Cholangitis

Sharma R, Dao KT, Garcia-Corella J, Dhillon H, Kalha I, Kim S, Stull WR, Petersen G. Unraveling the Complexity: A Case of Systemic Lupus Erythematosus,[...]